Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Melanoma”

577 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 577 results

Testing effectiveness (Phase 2)Ended earlyNCT01888081
What this trial is testing

A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma

Who this might be right for
Melanoma
Angimmune LLC 2
Early research (Phase 1)Study completedNCT00029900
What this trial is testing

ADI-PEG in Patients With Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
FDA Office of Orphan Products Development 15
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT02608034
What this trial is testing

Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State

Who this might be right for
Metastatic Melanoma, BRAF V600 Mutation Positive
Genentech, Inc. 32
Early research (Phase 1)Ended earlyNCT01810016
What this trial is testing

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Ludwig Institute for Cancer Research 8
Early research (Phase 1)Study completedNCT00438009
What this trial is testing

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

Who this might be right for
Stage IV Melanoma
Viralytics 9
Testing effectiveness (Phase 2)Ended earlyNCT01191034
What this trial is testing

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2
Early research (Phase 1)Study completedNCT01011530
What this trial is testing

Dose Escalation Study of MLN4924 in Adults With Melanoma

Who this might be right for
Metastatic Melanoma
Millennium Pharmaceuticals, Inc. 37
Testing effectiveness (Phase 2)WithdrawnNCT01531244
What this trial is testing

Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

Who this might be right for
Melanoma
Washington University School of Medicine
Early research (Phase 1)Study completedNCT01005472
What this trial is testing

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT01876212
What this trial is testing

Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Walter J. Storkus 15
Testing effectiveness (Phase 2)Study completedNCT00033228
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mannkind Corporation 19
Not applicableLooking for participantsNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Early research (Phase 1)Study completedNCT01986426
What this trial is testing

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Who this might be right for
CancerMelanomaBreast Cancer+3 more
Lytix Biopharma AS 80
Early research (Phase 1)Looking for participantsNCT03093909
What this trial is testing

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Who this might be right for
Malignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more
M.D. Anderson Cancer Center 44
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Early research (Phase 1)Study completedNCT00276536
What this trial is testing

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Breast CancerKidney CancerLymphoma+4 more
The Cleveland Clinic 35
Early research (Phase 1)Ended earlyNCT05831995
What this trial is testing

Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorRAS MutationRAF Mutation+1 more
ABM Therapeutics Corporation 12
Testing effectiveness (Phase 2)Looking for participantsNCT06961357
What this trial is testing

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 36
Load More Results